This product is not tested for potency. The minimum purity specification is 97.5%. The lot specific purity is reported in the Certificate of Analysis.
Fortfahren mit
SML1581
Moxifloxacin -hydrochlorid
98.0 to 102.0% (HPLC)
Synonym(e):
1-Cyclopropyl-6-fluor-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydrochinolin-3-carbonsäure -hydrochlorid
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
50 mg | Warenkorb auf Verfügbarkeit prüfen | € 92,60 |
250 mg | Warenkorb auf Verfügbarkeit prüfen | € 269,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C21H24FN3O4· HCl
CAS-Nummer:
Molekulargewicht:
437.89
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Beilstein/REAXYS Number:
8377447
Assay:
98-102% (HPLC)
Form:
powder
Storage condition:
desiccated
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
Moxifloxacin -hydrochlorid, 98-102% (HPLC)
Quality Segment
assay
98-102% (HPLC)
form
powder
storage condition
desiccated
color
light yellow to yellow
solubility
H2O: slightly soluble
storage temp.
−20°C
SMILES string
Cl.COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(O)=O
InChI
1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1
InChI key
IDIIJJHBXUESQI-DFIJPDEKSA-N
General description
Application
Moxifloxacin hydrochloride has been used to study its antibacterial action against bacteria that have grown to high density.
Biochem/physiol Actions
Moxifloxacin has proved to be effective in treating sinusitis, community-acquired respiratory tract infection, pneumonia and acute exacerbations of chronic bronchitis. It has improved anti-gram positive activity compared to other fluoroquinolone such as ciprofloxacin and ofloxacin. Moxifloxacin is useful in treating skin infections that is of bacterial origin. It is known to have proper penetration into peripheral tissues and inflammatory fluids. Fluoroquinolones stabilize DNA strand breaks created by DNA gyrase and topoisomerase IV by binding to the enzyme-DNA complex. Compared to mammalian DNA gyrase, moxifloxacin has 100 times higher affinity for bacterial DNA gyrase. Moxifloxacin is an antibiotic and works against both Gram-positive and Gram-negative bacteria. Moxifloxacin is being investigated for the treatment of multidrug-resistant tuberculosis.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description 98-102% (HPLC) | description VETRANAL®, analytical standard | description United States Pharmacopeia (USP) Reference Standard | description European Pharmacopoeia (EP) Reference Standard |
| form powder | form - | form - | form - |
| assay 98-102% (HPLC) | assay - | assay - | assay - |
| Quality Level 100 | Quality Level 100 | Quality Level - | Quality Level - |
| storage temp. −20°C | storage temp. 2-8°C | storage temp. - | storage temp. 2-8°C |
| solubility H2O: slightly soluble | solubility - | solubility - | solubility - |
| storage condition desiccated | storage condition - | storage condition - | storage condition - |
Still not finding the right product?
Explore all of our products under Moxifloxacin -hydrochlorid
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2
Lagerklasse
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
-
What is the minimum bactericidal concentration?
1 answer-
Helpful?
-